Why Is Unithroid So Hard to Find? [Explained for 2026]

If you've ever walked up to a pharmacy counter expecting to pick up your Unithroid prescription only to be told it's out of stock, you're not alone. Unithroid (levothyroxine sodium) is one of the most commonly prescribed drugs in the United States — and yet, patients consistently report trouble finding specific strengths at their local pharmacy. So what's going on?

The short answer: Unithroid is not officially in a national shortage as of 2026, but that doesn't mean it's sitting on every pharmacy shelf. A combination of high demand, narrow therapeutic index manufacturing requirements, supply chain variability, and pharmacy stocking decisions creates a situation where the drug is being made — but your specific strength may not be at your specific pharmacy on any given day.

What Is Unithroid and Why Is It So Widely Used?

Unithroid is a brand-name form of levothyroxine sodium, a synthetic version of T4 — the main hormone produced by your thyroid gland. It was the first levothyroxine product to receive FDA approval under a New Drug Application (NDA) back in August 2000, making it the reference standard for all other levothyroxine products.

Levothyroxine is prescribed to more than 120 million Americans every year, making it consistently one of the most-prescribed drugs in the country. It treats hypothyroidism, Hashimoto's thyroiditis, post-thyroidectomy hormone deficiency, and thyroid cancer. Because it manages a chronic condition requiring lifelong daily dosing, any availability issue — no matter how small — affects an enormous number of people.

Is Unithroid Actually in a Shortage in 2026?

As of 2026, oral levothyroxine tablets — including Unithroid — are not listed on the FDA's official drug shortage database. However, the FDA's list only captures shortages reported by manufacturers. If a drug is being produced but isn't reaching every pharmacy shelf, the FDA won't flag it as a shortage, even if thousands of patients can't fill their prescription.

In March 2025, Kaiser Permanente sent formal notifications to members about a "critical reduction" in the supply of generic levothyroxine tablets from their preferred manufacturer. While supply has since partially stabilized, certain strengths — particularly 137 mcg, 175 mcg, 200 mcg, and 300 mcg — continue to be intermittently unavailable at chain pharmacies in 2026.

Why Levothyroxine Is Especially Vulnerable to Availability Issues

Several structural factors make levothyroxine — including Unithroid — more susceptible to availability problems than most other drugs:

Narrow therapeutic index (NTI): Levothyroxine has a very narrow range between an effective dose and a harmful dose. This means manufacturing quality must be extremely precise — even a small deviation in potency can affect a patient's TSH levels. Strict quality control requirements slow production and create more opportunity for batch failures.

12 separate tablet strengths: Unithroid comes in 12 dosage strengths (25 mcg through 300 mcg). Each strength requires a separate production run, meaning manufacturers must manage 12 distinct SKUs. Less-common strengths get fewer production runs and are more prone to inventory gaps.

Multiple competing supply chains: Unithroid is made by Jerome Stevens Pharmaceuticals and distributed by Amneal. Other levothyroxine brands have their own manufacturers and distribution networks. Pharmacies may carry one manufacturer's product but not another's, based on their wholesaler relationship.

Brand-switching restrictions: Unlike most drugs, pharmacists cannot automatically substitute between branded levothyroxine products. Switching from Unithroid to Synthroid, Levoxyl, or Euthyrox requires a new prescription or prescriber authorization — because even small formulation differences can shift a patient's TSH.

High demand with chronic use: Because hypothyroidism is a lifelong condition, prescriptions don't stop — demand is continuous and predictable, but any disruption in supply creates an immediate gap for patients who can't miss a dose.

Which Unithroid Strengths Are Hardest to Find?

Common strengths (25, 50, 75, 100, and 125 mcg) are broadly available at most pharmacies in 2026. The strengths most likely to be out of stock at large chain pharmacies are:

137 mcg

175 mcg

200 mcg

300 mcg

Independent pharmacies often have more flexibility in ordering from multiple wholesalers, and may stock strengths that chain pharmacies don't carry as regularly.

A Brief History of Levothyroxine Shortages

Levothyroxine has had periodic supply disruptions for over a decade. The 2013 Levoxyl recall removed that brand from the market for nearly a year. The 2017 Puerto Rico hurricanes disrupted manufacturing for multiple levothyroxine brands, causing widespread availability issues — and prices temporarily jumped at Walmart from $4 to $9 for a 30-day supply. In 2025, manufacturing issues triggered the Kaiser Permanente supply reduction. These events underscore a pattern of ongoing fragility in the levothyroxine supply chain.

What Can You Do If Unithroid Is Out of Stock?

The most important thing is to not simply go without your medication. Hypothyroidism is a serious condition, and missing doses can cause symptoms to return quickly. Here are your options:

Search multiple pharmacies: Don't give up after one call. Use medfinder.com to have pharmacies near you checked for stock.

Try independent pharmacies: Independent pharmacies often source from multiple distributors and may stock Unithroid when chains don't.

Ask about a 90-day supply: When you do find it in stock, ask your doctor to prescribe a 90-day supply to reduce future refill risk.

Talk to your doctor about alternatives: If Unithroid is unavailable, other brand-name levothyroxine products like Synthroid, Levoxyl, or Euthyrox may be available at your pharmacy. See our guide on alternatives to Unithroid for details.

Consider mail-order pharmacy: Mail-order pharmacies through your insurance plan often maintain larger inventories and can ship directly to your door.

The Bottom Line

Unithroid is not in an official FDA shortage as of 2026, but real-world availability issues are real — especially for higher strengths and at large chain pharmacies. The combination of narrow therapeutic index manufacturing requirements, 12 separate dosage strengths, multiple competing supply chains, and brand-switching restrictions makes levothyroxine uniquely vulnerable to localized outages. If you're struggling to find Unithroid, medfinder can help you identify which pharmacies near you currently have your specific strength in stock.